gossypol has been researched along with tanespimycin in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, L; Dai, X; He, F; Li, X; Lian, J; Ni, Z; Qin, L; Wang, B; Wu, Y; Xu, L | 1 |
1 other study(ies) available for gossypol and tanespimycin
Article | Year |
---|---|
Hsp90 inhibitor 17-AAG sensitizes Bcl-2 inhibitor (-)-gossypol by suppressing ERK-mediated protective autophagy and Mcl-1 accumulation in hepatocellular carcinoma cells.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Beclin-1; Benzoquinones; Carcinoma, Hepatocellular; Cell Line, Tumor; Down-Regulation; Extracellular Signal-Regulated MAP Kinases; Gossypol; Hep G2 Cells; HSP90 Heat-Shock Proteins; Humans; Lactams, Macrocyclic; Liver Neoplasms; Membrane Proteins; Microtubule-Associated Proteins; Myeloid Cell Leukemia Sequence 1 Protein; Phosphorylation; Proto-Oncogene Proteins c-bcl-2 | 2014 |